Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants

May 23, 2024

https://www.globenewswire.com/news-release/2024/05/23/2887625/0/en/Genelux-Corporation-Announces-Proposed-Public-Offering-of-Common-Stock-and-Warrants.html

WESTLAKE VILLAGE, Calif., May 23, 2024 (GLOBE NEWSWIRE) — Genelux Corporation (Genelux) (Nasdaq:GNLX), a late clinical-stage immuno-oncology company, today announced that it has commenced an underwritten public offering of its common stock and accompanying warrants. All shares of common stock and accompanying warrants are being offered by Genelux. In addition, Genelux expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock sold in connection with the offering (including shares underlying the warrants).

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.